Alabama Access

Aspire Is Excited To Apply For A Vertically Integrated License In Alabama. The SB46 Statute Provides For A Healthy And Well Thought-Out Medical Program That Aligns Well Will Aspire’s Commitment To R&D In Medical Cannabis Supply-Chain Innovation Through Agricultural R&D, As Well As Improving Product Efficacy Through Medical And Pharmaceutical R&D – Beginning With The Fundamentals Of Plant Genetics Research.

Aspire has chosen to partner with a best-in-class team with a proven track records individually as well as through collaborations as a group. These three core partners are the foundation of Aspire’s multi-state R&D vertical. By providing genetics and agricultural R&D, they offer the ability for our team to understand the fundamentals of the plant and its environment to open the door for discoveries in cultivation and formulation that can be applied through supply-chain innovation and medical/pharmaceutical applications. Aspire’s best-practices can also serve as the foundation for educational programs to be established and offered through our educational partner to help improve Alabama’s medical cannabis work force, as well as make the State a center of excellence for medical cannabis education.

Located in Limestone County, Bridgeforth Family Farms is a 5th generation, black owned and operated, family company. The Farm has been involved in numerous research projects with Alabama A&M, including the production of hemp and canola.

Hudson Alpha will collaborate with Aspire through R&D and Ag-tech Accelerator/Aspire Living Labs, Research plant genomics and develop innovations for medical, pharmaceutical, & agricultural applications.

Headquartered in Limestone County, Claborn Holdings has numerous locations throughout Alabama. The Inc. 5000 company is family owned and operates one of the fastest growing and largest contracting companies in the State.

Alabama A&M will collaborate with Aspire through R&D and Education Development, research industrial applications for medical cannabis and develop educational programs.

Alabama Medical Program

Alabama is in its first phases of enacting a medical cannabis program, and we can follow the projected journey of the program by understanding the programs in states that introduced medical cannabis legislation as early as 2014.

5

Vertically Integrated Licenses

4

Processor Licenses

1

Cultivation License

4

Dispensary Licenses

Vertically integrated licenses which may grow, process, transport, and dispense cannabis. Each may have up to five dispensing sites, in different counties. The commission can increase the number of sites to meet demand.

Dispensary licenses which may have up to three locations in different counties than other sites; starting one year post-licensing, more dispensing sites can be approved if the patient pool warrants them.

16 Qualifying Medical Conditions

Autism Spectrum Disorder (ASD)
Cancer-related cachexia, nausea or vomiting, weight loss, or chronic pain
Cohn’s Disease
Depression
Epilepsy or a condition causing seizures
HIV/AIDS-related nausea or weight loss
Panic disorder
Parkinson’s disease
Post Traumatic Stress Disorder (PTSD)
Sickle Cell Anemia

Terminal illness
Tourette’s Syndrome
Persistent nausea that is not significantly responsive to traditional treatment, except for nausea related to pregnancy,
Cannabis-induced cyclical vomiting syndrome, or cannabinoid hyperemesis syndrome
Spasticity associated with a motor neuron disease, Multiple Sclerosis, or a spinal cord injury
A condition causing chronic or intractable pain in which conventional therapeutic intervention and opiate therapy is contraindicated or has proved ineffective

Alabama Poised to Lead U.S. Cannabis Research & Development

Alabama has an opportunity to become a national center of excellence in medical cannabis IF…

The procurement process is done well enough to significantly mitigate or eliminate litigation, which is very time consuming and costly.
Well-qualified operators are selected who are capitalized enough to build facilities, operate through a financial deficit, and weather the early market challenges.
Roll-out of the industry goes smoothly so that operators are able get product to patients without delay.
Research and development are a priority to allow the Alabama institutions and businesses to lead
innovation nationally, leading to economic and educational development.

Alabama poised to lead nation in cannabis R&D

In an effort to promote a transparent and meritocratic procurement process, Aspire is providing open access to a white paper as a resource for any members of the general public or potential medical-cannabis-license applicants who are inclined to opine on Alabama’s rules and regulations as those become available to the public. The white paper presents trends in national litigation against states during medical-cannabis-license procurements and potential areas of risk associated with currently published Alabama statutes.

Medical Cannabis Procurement White Paper